Inventor
CAMERON KIMBERLY O
US28 patents
⚠️ This page may combine multiple inventors who share the name “CAMERON KIMBERLY O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
27 patentsUS5552412ASep 3, 1996
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
PFIZER194 citations99
US6552067B2Apr 22, 2003
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER57 citations96
US6441193B1Aug 27, 2002
Estrogen agonists/antagonists
PFIZER28 citations96
US6204286B1Mar 20, 2001
Estrogen agonists/antagonists
PFIZER62 citations96
US6153622ANov 28, 2000
Estrogen agonists/antagonists
PFIZER59 citations96
US6747054B2Jun 8, 2004
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER24 citations92
US6649657B2Nov 18, 2003
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER16 citations92
US6498172B1Dec 24, 2002
Prostaglandin agonists and their use to treat bone disorders
PFIZER25 citations92
US6288120B1Sep 11, 2001
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER30 citations92
US6124314ASep 26, 2000
Osteoporosis compounds
PFIZER42 citations92
US5703108ADec 30, 1997
Bone deposition by certain prostaglandin agonists
PFIZER35 citations92
US7265104B2Sep 4, 2007
Tetraazabenzo[e]azulene derivatives and analogs thereof
PFIZER13 citations84
USRE39558EApr 10, 2007
5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosis
PFIZER10 citations84
US6531485B2Mar 11, 2003
Prostaglandin agonists
PFIZER18 citations84
US6608203B2Aug 19, 2003
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
PFIZER13 citations83
US7192979B2Mar 20, 2007
EP4 receptor selective agonist in the treatment of osteoporosis
PFIZER7 citations74
US6376502B1Apr 23, 2002
Osteoporosis compounds
PFIZER6 citations74
US6492412B2Dec 10, 2002
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER9 citations73
US6426359B1Jul 30, 2002
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
PFIZER12 citations73
US6852863B2Feb 8, 2005
Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
PFIZER7 citations71
US6756388B1Jun 29, 2004
Benzothiophenes and related compounds as estrogen agonists
PFIZER11 citations71
US7442702B2Oct 28, 2008
Prostaglandin agonists
PFIZER2 citations63
US7053212B2May 30, 2006
Acyclic amide and sulfonamide ligands for the estrogen receptor
PFIZER4 citations63
US6998423B2Feb 14, 2006
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER2 citations62
US7414071B2Aug 19, 2008
Methods of treatment with selective EP4 receptor agonists
PFIZER6 citations60
US7358242B2Apr 15, 2008
Tetraazabenzo[e]azulene derivatives and analogs thereof
PFIZER1 citations52
US11203594B2Dec 21, 2021
Anti-proliferative agents for treating PAH
PFIZER0 citations50